Loading...
XSHG
603896
Market cap557mUSD
Dec 05, Last price  
19.93CNY
1D
0.20%
1Q
-6.43%
Name

Zhejiang Shouxiangu Pharmaceuticl Co Ltd

Chart & Performance

D1W1MN
XSHG:603896 chart
P/E
22.61
P/S
5.71
EPS
0.88
Div Yield, %
1.96%
Shrs. gr., 5y
1.61%
Rev. gr., 5y
4.81%
Revenues
692m
-11.81%
177,752,928253,030,064301,591,563301,912,435314,879,954369,963,314511,451,922546,758,533636,050,563767,137,327829,071,599784,347,256691,683,550
Net income
175m
-31.34%
34,022,82154,048,12869,251,16462,643,86180,977,81688,879,887107,652,897123,895,326151,712,138200,826,526277,783,036254,480,058174,714,540
CFO
213m
-32.25%
45,356,80765,849,813102,899,07585,029,30095,516,877110,803,595171,513,111207,918,192256,358,637296,699,128341,283,418315,057,385213,440,267
Dividend
Jun 20, 20240.39 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale, crocus sativus, and other health products. The company was founded in 1997 and is based in Jinhua, China.
IPO date
Employees
Domiciled in
BE
Incorporated in
BE

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT